Skip to main content
Premium Trial:

Request an Annual Quote

Genizon, Speid Partner on Predictive Drug Technology

NEW YORK (GenomeWeb News) – Genizon BioSciences has entered into a partnership with drug development consultancy Speid & Associates to offer that firm's clients access to Genizon's predictive techniques in the drug development process.

Speid's customers will use Genizon's genetic platform to identify and eliminate compounds that have a relatively low chance of success early in the drug development cycle.

"The combination of Genizon's proprietary gene discovery platform and Speid's expertise in regulatory affairs will assure expeditious pathways to commercialization," Genizon CSO and Founder Majid Belouchi, said in a statement.

Financial and other terms of the pact were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.